TrialAdvances in therapy2024

A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers.

Joseph V Pergolizzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.